dehydroretronecine has been researched along with senecionine n-oxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buhler, DR; Guengerich, FP; Miranda, CL; Reed, RL | 1 |
| Buhler, DR; Kedzierski, B; Miranda, CL; Reed, RL | 1 |
2 other study(ies) available for dehydroretronecine and senecionine n-oxide
| Article | Year |
|---|---|
Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver.
Topics: Antineoplastic Agents, Phytogenic; Carcinogens; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Immunoglobulin G; Kinetics; Liver; Microsomes, Liver; Mixed Function Oxygenases; Monocrotaline; Norpregnenes; Oxidation-Reduction; Pyrrolizidine Alkaloids; Troleandomycin | 1991 |
Mechanisms for pyrrolizidine alkaloid activation and detoxification.
Topics: Animals; Biotransformation; Glutathione; In Vitro Techniques; Inactivation, Metabolic; Male; Microsomes, Liver; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1991 |